These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 188506)

  • 21. Cholecystokinin, dopamine and schizophrenia.
    Garver DL; Beinfeld MC; Yao JK
    Psychopharmacol Bull; 1990; 26(3):377-80. PubMed ID: 2274639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes.
    Nikkilä HV; Müller K; Ahokas A; Miettinen K; Rimón R; Andersson LC
    Am J Psychiatry; 1999 Nov; 156(11):1725-9. PubMed ID: 10553735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the cerebrospinal fluid levels of adenosine cyclic- 3',5'-monophosphate (c-AMP) in patients with generalized tonic-clonic epileptic seizures].
    Szczechowski L; Wajgt A; Marczewska E
    Neurol Neurochir Pol; 1991; 25(3):332-6. PubMed ID: 1660110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Geisler A; Bech P; Johannesen M; Rafaelsen OJ
    Neuropsychobiology; 1976; 2(4):211-20. PubMed ID: 189250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic AMP in CSF of patients with neurologic disease.
    Vapaatalo H; Myllylä V; Heikkinen E; Hokkanen E
    N Engl J Med; 1977 Mar; 296(12):691-2. PubMed ID: 190539
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia.
    Prasad C; Hilton CW; Lohr JB; Robertson HJ
    Neuropeptides; 1991 Nov; 20(3):187-90. PubMed ID: 1762668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdaloid kindling and cerebrospinal cyclic nucleotides.
    Sato M; Akiyama T; Yamashita M; Okamoto M; Otsuki S
    Biol Psychiatry; 1981 Aug; 16(8):763-71. PubMed ID: 6269662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYCLIC AMP/*SECRETl cyclic AMP into push-pull perfusates in freely moving rats.
    Korf J; Boer PH; Fekkes D
    Brain Res; 1976 Sep; 113(3):551-61. PubMed ID: 182325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients.
    Covicković-Sternić N; Kostić VS; Djuricić BM; Bumbasirević-Beslać L; Nikolić M; Mrsulja BB
    Eur Neurol; 1987; 27(1):24-8. PubMed ID: 3040416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF.
    Zarcone V; Schreier L; Barchas J; Orenberg E; Benson K
    Adv Exp Med Biol; 1977; 85A():593-9. PubMed ID: 200121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
    Nemtsov AV; Kalinin VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1232-41. PubMed ID: 6171962
    [No Abstract]   [Full Text] [Related]  

  • 32. CSF cyclic AMP changes in nervous system inflammatory diseases.
    Wei GZ; Xu C; Liu SY; Yang CL
    Chin Med J (Engl); 1982 Aug; 95(8):605-8. PubMed ID: 6291872
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of oral melatonin administration on melatonin, 5-hydroxyindoleacetic acid, indoleacetic acid, and cyclic nucleotides in human cerebrospinal fluid.
    Young SN; Gauthier S; Kiely ME; Lal S; Brown GM
    Neuroendocrinology; 1984 Jul; 39(1):87-92. PubMed ID: 6205317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF copper in schizophrenia.
    Tyrer SP; Delves HT; Weller MP
    Am J Psychiatry; 1979 Jul; 136(7):937-9. PubMed ID: 453356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients.
    Kafka MS; Kleinman JE; Karson CN; Wyatt RJ
    Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.
    van Kammen DP; Kelley ME; Gilbertson MW; Gurklis J; O'Connor DT
    Am J Psychiatry; 1994 Mar; 151(3):372-8. PubMed ID: 8109645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pimozide on CSF norepinephrine in schizophrenia.
    Sternberg DE; van Kammen DP; Lake CR; Ballenger JC; Marder SR; Bunney WE
    Am J Psychiatry; 1981 Aug; 138(8):1045-50. PubMed ID: 7258379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gamma-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia.
    McCarthy BW; Gomes UR; Neethling AC; Shanley BC; Taljaard JJ; Potgieter L; Roux JT
    J Neurochem; 1981 Apr; 36(4):1406-8. PubMed ID: 7264636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic AMP in cereborspinal fluid of rats: effects of electroconvulsive shock.
    Clarenbach PA; Wenzel DC; Cramer HL
    Eur Neurol; 1978; 17(2):83-6. PubMed ID: 204488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ; Leahey W; Green DF; King DJ
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.